Viewing Study NCT01328106


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-26 @ 11:00 AM
Study NCT ID: NCT01328106
Status: WITHDRAWN
Last Update Posted: 2017-12-12
First Post: 2010-03-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module